Endospan
FDA Grants NEXUS Aortic Arch Stent Graft System Breakthrough Designation
The designation of NEXUSTM Aortic Arch Stent Graft System as a breakthrough device acknowledges the unmet need in this patient population and the potential for improvements over current standard treatments.
